Ipsos Survey On Avian Flu

New York, NY -- According to a survey conducted by Ipsos Public Affairs, levels of concern about avian (or bird) flu have diminished in the United States over the last 12 months.

Currently, about one quarter of respondents (27%) indicate more than a moderate level of concern about avian flu in the United States generally, down eight percentage points from last year. However, these concerns seem concentrated at a general level, with fewer respondents indicating avian flu is a threat to personal health. Only 15% of respondents report more than a moderate level of concern about avian flu as a risk to themselves or their families.

At the same time that concerns regarding avian flu are ebbing in the United States, other statistics suggest the numbers of human cases of avian flu may be stabilizing. Statistics provided by the World Health Organization (WHO) suggest that the total number of confirmed cases in 2007 (50 up until mid-June) may be no higher than those reported in 2006 (115 for the whole year).

Recall of news coverage about avian flu is also on the decline. The proportion of Americans saying they have read, heard or seen at least some coverage about it is now 56%, down 18 percentage points from 74% a year ago.

A majority of Americans (62%) now feel that government leaders are giving enough attention to the issue. Nearly a third (32%), however, would like to see avian flu given a greater focus.

As in 2006, the vast majority of Americans report that news about avian flu is not impacting their eating habits when it comes to poultry or poultry products: roughly nine in ten say that there has been no change in their consumption of each of chicken, turkey or eggs.

Methodology The survey was conducted online among 1,438 U.S. adults aged 18 and over interviewed between June 7 and 17, 2007 with Ipsos' Online Omnibus. Results are demographically balanced to represent the population of adults aged 18 and over in the United States. The margin of error is + 3.1 percentage points with a 95% level of confidence.

For more information on this press release, please contact: Annabel Evans Vice President Ipsos Public Affairs New York, NY (212) 584-9266 Annabel.Evans@Ipsos-NA.com

About Ipsos Public Affairs Ipsos Public Affairs is one of the company's five research specializations. In the US, it has offices in New York City, Washington, DC, Chicago and Seattle. It specializes in corporate reputation, issues management, strategic communications and sociopolitical trends, serving the needs of corporations, non-profit organizations, public relations firms, news media and governments. Its toolbox for conducting tailor-made solutions includes rapid turnaround quantitative polling, qualitative focus groups, online panels, elite and stakeholder interviewing, syndicated subscriptions, and proprietary research techniques. Ipsos Public Affairs is well known as the polling partner of The Associated Press, the world's oldest and largest news organization.

To learn more, visit: www.ipsos-na.com/pa

About Ipsos Ipsos is a leading global survey-based market research company, owned and managed by research professionals. Ipsos helps interpret, simulate, and anticipate the needs and responses of consumers, customers, and citizens around the world.

Member companies assess market potential and interpret market trends. They develop and build brands. They help clients build long-term relationships with their customers. They test advertising and study audience responses to various media. They measure public opinion around the globe.

Ipsos member companies offer expertise in advertising, customer loyalty, marketing, media, and public affairs research, as well as forecasting, modelling, and consulting. Ipsos has a full line of custom, syndicated, omnibus, panel, and online research products and services, guided by industry experts and bolstered by advanced analytics and methodologies. The company was founded in 1975 and has been publicly traded since 1999. In 2006, Ipsos generated global revenues of e857.3 million ($1,076.3 million U.S.).

Visit www.ipsos.com to learn more about Ipsos offerings and capabilities.

Ipsos, listed on the Eurolist of Euronext - Comp B, is part of SBF 120 and the Mid-100 Index, adheres to the Next Prime segment and is eligible to the Deferred Settlement System. Isin FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP

More insights about Health